PURPOSE: To evaluate gold marker displacement due to needle insertion during HDR-brachytherapy for therapy of prostate cancer.
PATIENTS AND METHODS: 18 patients entered into this prospective evaluation. Three gold markers were implanted into the prostate during the first HDR-brachytherapy procedure after the irradiation was administered. Three days after marker implantation all patients had a CT-scan for planning purpose of the percutaneous irradiation. Marker localization was defined on the digitally-reconstructed-radiographs (DRR) for daily (VMAT technique) or weekly (IMRT) set-up error correction. Percutaneous therapy started one week after first HDR-brachytherapy. After the second HDR-brachytherapy, two weeks after first HDR-brachtherapy, a cone-beam CT-scan was done to evaluate marker displacement due to needle insertion. In case of marker displacement, the actual positions of the gold markers were adjusted on the DRR.
RESULTS: The value of the gold marker displacement due to the second HDR-brachytherapy was analyzed in all patients and for each gold marker by comparison of the marker positions in the prostate after soft tissue registration of the prostate of the CT-scans prior the first and second HDR-brachytherapy. The maximum deviation was 5 mm, 7 mm and 12 mm for the anterior-posterior, lateral and superior-inferior direction. At least one marker in each patient showed a significant displacement and therefore new marker positions were adjusted on the DRRs for the ongoing percutaneous therapy.
CONCLUSIONS: Needle insertion in the prostate due to HDR-brachytherapy can lead to gold marker displacements. Therefore, it is necessary to verify the actual position of markers after the second HDR-brachytherapy. In case of significant deviations, a new DRR with the adjusted marker positions should be generated for precise positioning during the ongoing percutaneous irradiation.
Written by:
Herrmann MK, Kertesz T, Gsänger T, Bloch E, Pollul G, Bouabdallaoui M, Strauss A, Herrmann M, Christiansen H, Wolff HA, Hess CF, Hille A. Are you the author?
Department of Radiotherapy, University of Goettingen, Goettingen, Germany.
Reference: Radiat Oncol. 2012 Feb 20;7:24.
doi: 10.1186/1748-717X-7-24
PubMed Abstract
PMID: 22348595
